Cargando…
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance
Aldehyde dehydrogenases (ALDHs) are a family of detoxifying enzymes often upregulated in cancer cells and associated with therapeutic resistance. In humans, the ALDH family comprises 19 isoenzymes active in the majority of mammalian tissues. Each ALDH isoform has a specific differential expression p...
Autores principales: | Zanoni, Michele, Bravaccini, Sara, Fabbri, Francesco, Arienti, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920988/ https://www.ncbi.nlm.nih.gov/pubmed/35299840 http://dx.doi.org/10.3389/fmed.2022.795762 |
Ejemplares similares
-
ALDH1A3 Is the Key Isoform That Contributes to Aldehyde Dehydrogenase Activity and Affects in Vitro Proliferation in Cardiac Atrial Appendage Progenitor Cells
por: Puttini, Stefania, et al.
Publicado: (2018) -
Emerging roles of purinergic signaling in anti-cancer therapy resistance
por: Zanoni, Michele, et al.
Publicado: (2022) -
Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target
por: Quattrini, Luca, et al.
Publicado: (2020) -
Aldehyde Dehydrogenase Isoform 1 Predicts a Poor Prognosis of Acute Cerebral Infarction
por: Yang, Jing, et al.
Publicado: (2022) -
Editorial: Aldehyde dehydrogenase in clinical settings: Potential biomarker and therapeutic target in solid tumors
por: Aramini, Beatrice, et al.
Publicado: (2023)